These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
669 related articles for article (PubMed ID: 27903248)
1. Long-term clinical course of anti-glycyl tRNA synthetase (anti-EJ) antibody-related interstitial lung disease pathologically proven by surgical lung biopsy. Sasano H; Hagiwara E; Kitamura H; Enomoto Y; Matsuo N; Baba T; Iso S; Okudela K; Iwasawa T; Sato S; Suzuki Y; Takemura T; Ogura T BMC Pulm Med; 2016 Dec; 16(1):168. PubMed ID: 27903248 [TBL] [Abstract][Full Text] [Related]
2. Clinical features of anti-synthetase syndrome associated interstitial lung disease: a retrospective cohort in China. Zhan X; Yan W; Wang Y; Li Q; Shi X; Gao Y; Ye Q BMC Pulm Med; 2021 Feb; 21(1):57. PubMed ID: 33579248 [TBL] [Abstract][Full Text] [Related]
3. Clinical features and outcomes of the patients with anti-glycyl tRNA synthetase syndrome. Zhang Y; Ge Y; Yang H; Chen H; Tian X; Huang Z; Liu S; Lu X; Wang G Clin Rheumatol; 2020 Aug; 39(8):2417-2424. PubMed ID: 32144624 [TBL] [Abstract][Full Text] [Related]
4. Clinical and pathological findings of interstitial lung disease patients with anti-aminoacyl-tRNA synthetase autoantibodies. Koreeda Y; Higashimoto I; Yamamoto M; Takahashi M; Kaji K; Fujimoto M; Kuwana M; Fukuda Y Intern Med; 2010; 49(5):361-9. PubMed ID: 20190466 [TBL] [Abstract][Full Text] [Related]
5. Clinical characteristics of patients with anti-EJ antisynthetase syndrome associated interstitial lung disease and literature review. Liu Y; Liu X; Xie M; Chen Z; He J; Wang Z; Dai J; Cai H Respir Med; 2020; 165():105920. PubMed ID: 32174452 [TBL] [Abstract][Full Text] [Related]
6. Establishment of an ELISA to detect anti-glycyl-tRNA synthetase antibody (anti-EJ), a serological marker of dermatomyositis/polymyositis and interstitial lung disease. Hane H; Muro Y; Watanabe K; Ogawa Y; Sugiura K; Akiyama M Clin Chim Acta; 2014 Apr; 431():9-14. PubMed ID: 24508626 [TBL] [Abstract][Full Text] [Related]
7. Clinical, radiological, and pathological features of anti-asparaginyl tRNA synthetase antibody-related interstitial lung disease. Aiko N; Yamakawa H; Iwasawa T; Takemura T; Okudela K; Kitamura H; Hagiwara E; Ikeda S; Baba T; Iso S; Yamaguchi Y; Kondo Y; Kurabayashi T; Ohashi K; Sato S; Ogura T Respir Investig; 2020 May; 58(3):196-203. PubMed ID: 32094078 [TBL] [Abstract][Full Text] [Related]
11. Clinical significance of radiological patterns of HRCT and their association with macrophage activation in dermatomyositis. Zuo Y; Ye L; Liu M; Li S; Liu W; Chen F; Lu X; Gordon P; Wang G; Shu X Rheumatology (Oxford); 2020 Oct; 59(10):2829-2837. PubMed ID: 32065646 [TBL] [Abstract][Full Text] [Related]
14. Clinical features and natural history of interstitial pneumonia with autoimmune features: A single center experience. Chartrand S; Swigris JJ; Stanchev L; Lee JS; Brown KK; Fischer A Respir Med; 2016 Oct; 119():150-154. PubMed ID: 27692137 [TBL] [Abstract][Full Text] [Related]
15. [Clinico-pathological manifestations in interstitial lung diseases associated with polymyositis-dermatomyositis]. Shi JH; Xu WB; Liu HR; Tian XL; Feng RE; Xu ZJ; Zhu YJ Zhonghua Jie He He Hu Xi Za Zhi; 2008 Apr; 31(4):250-4. PubMed ID: 18846959 [TBL] [Abstract][Full Text] [Related]
16. Interstitial lung disease outcomes by high-resolution computed tomography (HRCT) in Anti-Jo1 antibody-positive polymyositis patients: a single centre study and review of the literature. Ingegnoli F; Lubatti C; Ingegnoli A; Boracchi P; Zeni S; Meroni PL Autoimmun Rev; 2012 Mar; 11(5):335-40. PubMed ID: 21985773 [TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of anti-aminoacyl-tRNA synthetase antibodies in polymyositis/dermatomyositis-associated interstitial lung disease: a retrospective case control study. Hozumi H; Enomoto N; Kono M; Fujisawa T; Inui N; Nakamura Y; Sumikawa H; Johkoh T; Nakashima R; Imura Y; Mimori T; Suda T PLoS One; 2015; 10(3):e0120313. PubMed ID: 25789468 [TBL] [Abstract][Full Text] [Related]
18. Differences in clinical features and prognosis of interstitial lung diseases between polymyositis and dermatomyositis. Fujisawa T; Suda T; Nakamura Y; Enomoto N; Ide K; Toyoshima M; Uchiyama H; Tamura R; Ida M; Yagi T; Yasuda K; Genma H; Hayakawa H; Chida K; Nakamura H J Rheumatol; 2005 Jan; 32(1):58-64. PubMed ID: 15630726 [TBL] [Abstract][Full Text] [Related]
19. Two distinct clinical types of interstitial lung disease associated with polymyositis-dermatomyositis. Won Huh J; Soon Kim D; Keun Lee C; Yoo B; Bum Seo J; Kitaichi M; Colby TV Respir Med; 2007 Aug; 101(8):1761-9. PubMed ID: 17428649 [TBL] [Abstract][Full Text] [Related]
20. Common and distinct clinical features in adult patients with anti-aminoacyl-tRNA synthetase antibodies: heterogeneity within the syndrome. Hamaguchi Y; Fujimoto M; Matsushita T; Kaji K; Komura K; Hasegawa M; Kodera M; Muroi E; Fujikawa K; Seishima M; Yamada H; Yamada R; Sato S; Takehara K; Kuwana M PLoS One; 2013; 8(4):e60442. PubMed ID: 23573256 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]